Since GBMs are characterized by a very high number of genetic alterations causing changes in proliferation, migration, and invasiveness of tumor cells [58], it is very likely that one downstream effector molecule of GPR55 might be mutated in GBM #23, resulting in a disruption or a shift of its signaling. The gene discussed is GPR55; the disease is neoplasm.